reports
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences...
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate at the following investor conferences: TD Cowen's Immunology & Inflammation Summit (Virtual) - fireside chat on Wednesday, November 12, 2025, at 11:30 a.m. ET 2025 Jefferies Global Healthcare Conference in London - firesi...
- Wedbush Research
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MNKD MANNKIND CORP.
MELI MERCADOLIBRE INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
EBAY EBAY INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
NTLA INTELLIA THERAPEUTICS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
AMD ADVANCED MICRO DEVICES INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
TENB TENABLE HOLDINGS
SMCI SUPER MICRO COMPUTER
STTK INC.
BEAM SHATTUCK LABS
FUBO BEAM THERAPEUTICS
U FUBOTV
TVTX UNITY SOFTWARE
RZLT TRAVERE THERAPEUTICS INC
UFPI REZOLUTE
SANA UFP INDUSTRIES INC.
STX SANA BIOTECHNOLOGY
TCRX SEAGATE TECHNOLOGY HLDGS PLC
APP TSCAN THERAPEUTICS INC
ARTV APPLOVIN CORP
PRME ARTIVA BIOTHERAPEUTICS INC
SYRE PRIME MEDICINE INC
RNAC SPYRE THERAPEUTICS INC.
ZBIO CARTESIAN THERAPEUTICS INC
MAZE ZENAS BIOPHARMA INC.
JBIO MAZE THERAPEUTICS INC
JADE BIOSCIENCES INC
- David Nierengarten
- Dennis Pak
- Martin Fan
Moody's Ratings assigns Baa2 rating to HCA's proposed senior unsecured...
Moody's Ratings (Moody's) assigned Baa2 ratings to HCA Inc.'s ("HCA") proposed offering of backed senior unsecured notes of up to $3.25 billion with various maturities. HCA intends to use the net proceeds from this offering for general corporate purposes including repayment of outstanding borrowings...
Moody's Ratings upgrades HCA Inc.'s senior unsecured debt rating to Ba...
Moody's Ratings (Moody's) upgraded the ratings of HCA Inc.'s ("HCA") senior unsecured debt (which includes senior unsecured debentures/notes, backed senior unsecured notes and the senior unsecured bank credit facility) to Baa2 from Baa3. We also upgraded the backed commercial paper rating to P-2 fro...
Moody's Ratings affirms Tenet Healthcare Corporation's Ba3 CFR; revis...
Moody's Ratings (Moody's) affirmed the ratings of Tenet Healthcare Corporation ("Tenet") including the Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rating (PDR), Ba3 ratings of senior secured first and second lien notes and B2 rating of senior unsecured notes. At the same time, w...
The Ensign Group Schedules Third Quarter Earnings Call for Tuesday, No...
The Ensign Group Schedules Third Quarter Earnings Call for Tuesday, November 4, 2025 SAN JUAN CAPISTRANO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it expects to issue its third quarter 2025 financial results on Monday, November 3, 2025. Conference Call Ensign invites current and prospective inve...
- Seth Basham
WDC WESTERN DIGITAL CORPORATION
ORCL ORACLE CORPORATION
NVDA NVIDIA CORPORATION
MU MICRON TECHNOLOGY INC.
IMAX IMAX CORPORATION
INOD INNODATA
ARGX ARGENX ADS
MSFT MICROSOFT CORPORATION
LYFT LYFT
UBER UBER TECHNOLOGIES INC.
SNOW SNOWFLAKE INC. CLASS A
ARTV ARTIVA BIOTHERAPEUTICS INC
SNDK SANDISK CORP
STUB STUBHUB HOLDINGS INC.
- Dave Nicoski
- Ross LaDuke
WAT WATERS CORPORATION
TECH BIO-TECHNE CORPORATION
SSTK SHUTTERSTOCK INC.
EVEREST RE GROUP LTD.
FORM FORMFACTOR INC.
COLB COLUMBIA BANKING SYSTEM INC.
ANDE ANDERSONS INC.
ACHC ACADIA HEALTHCARE COMPANY INC.
MET METLIFE INC.
HP HELMERICH & PAYNE INC.
RELL RICHARDSON ELECTRONICS LTD.
COKE COCA-COLA CONSOLIDATED INC.
AMRK AMARK PRECIOUS METALS
BLNK BLINK CHARGING
CABA CABALETTA BIO
DYN DYNE THERAPEUTICS
CGEM CULLINAN ONCOLOGY INC
CVRX CVRX INC
ABSI ABSCI CORP
PNI PIMCO NEW YORK MUNICIPAL FUND II
EE EXCELERATE ENERGY INC
RDZN ROADZEN INC
ARDT ARDENT HEALTH PARTNERS INC
FCEL FUELCELL ENERGY INC.
- Wedbush Research
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SMCI SUPER MICRO COMPUTER
RVMD INC.
VRDN REVOLUTION MEDICINES
STX VIRIDIAN THERAPEUTICS INC
GFS SEAGATE TECHNOLOGY HLDGS PLC
GMTX GLOBALFOUNDRIES INC
ARTV GEMINI THERAPEUTICS INC
ARTIVA BIOTHERAPEUTICS INC
- David Nierengarten
- Dennis Pak
- Martin Fan
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Le...
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK in refractory RA, representing the first drug candidate in the deep B-cell depleting category to receive this designation with the potential to become the first in the category to advance to a pivotal trial in RA, pending FDA feedback expected in 1H 2026 Continued execution and enrollment progress with more than 20 pa...
- Wedbush Research
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
FATE FATE THERAPEUTICS INC
CRM SALESFORCE.COM INC.
AXTI AXT INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
AMD ADVANCED MICRO DEVICES INC.
GM GENERAL MOTORS COMPANY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SMCI SUPER MICRO COMPUTER
ACET INC.
RZLT ADICET BIO INC
SANA REZOLUTE
STX SANA BIOTECHNOLOGY
GFS SEAGATE TECHNOLOGY HLDGS PLC
ARTV GLOBALFOUNDRIES INC
RNAC ARTIVA BIOTHERAPEUTICS INC
CARTESIAN THERAPEUTICS INC
- David Nierengarten
- Dennis Pak
- Geoffrey Von Der Ahe
- Martin Fan
- Ritika Das
- Robert Driscoll
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Shar...
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share SAN JUAN CAPISTRANO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.0625 per share of Ensign common stock, payable on or before October 31, 2025, to shareholders of record as of Septem...
Tenet Healthcare Corp: 1 director
A director at Tenet Healthcare Corp sold 78,762 shares at 190.779USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare ...
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025 SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 9:45 a.m. EDT. Members of the Artiva management team will also be available to participate in investor meetings wit...
- Wedbush Research
FATE FATE THERAPEUTICS INC
BIIB BIOGEN INC.
SE SEA ADS
STOK STOKE THERAPEUTICS
PASG PASSAGE BIO
ORIC ORIC PHARMACEUTICALS
GBIO GENERATION BIO
VOR VOR BIOPHARMA
PHVS PHARVARIS NV
ATXS ASTRIA THERAPEUTICS INC
ARTV ARTIVA BIOTHERAPEUTICS INC
SLDB SOLID BIOSCIENCES INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
RNAC CARTESIAN THERAPEUTICS INC
MAZE MAZE THERAPEUTICS INC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.